Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration
暂无分享,去创建一个
B. Sugarman | M. Printz | D. Kang | R. Paladini | Yan Wang | Michael J. LaBarre | Michael C. Jorge | Daniel C. Maneval | D. Maneval